A clinician's guide for conducting randomized trials in individual patients

Area of Science:

• Clinical Pharmacology
• Evidence-Based Medicine
• Biostatistics

Background:

• Conventional clinical trials are often impractical or biased for determining optimal patient treatment.
• Large-scale randomized trials provide limited guidance for most clinical disorders.
• Individualized treatment decisions require methods less susceptible to bias than standard approaches.

Purpose of the Study:

• To present a practical approach for clinicians to conduct N of 1 randomized controlled trials (RCTs).
• To offer a solution for optimizing treatment in individual patients when standard trials are not feasible.
• To demonstrate how N of 1 RCTs can address the limitations of conventional therapeutic trials.

Main Methods:

• N of 1 RCTs involve pairs of randomized, blinded treatment periods (active drug vs. placebo) for individual patients.
• Treatment effectiveness is monitored using quantitative measures of symptoms, often via patient diaries or questionnaires.
• The process requires pharmacy cooperation for placebo preparation and adherence to blinding protocols.

Main Results:

• N of 1 RCTs are suitable for chronic, stable conditions where treatments have a rapid onset and offset of action.
• Treatment periods continue until the effectiveness of the intervention is clearly demonstrated or refuted.
• Formal statistical analysis can aid in interpreting the trial outcomes.

Conclusions:

• N of 1 RCTs provide a valuable tool for personalized medicine, overcoming limitations of traditional trial designs.
• Clinicians can implement this practical methodology to guide optimal treatment selection for individual patients.
• This approach enhances evidence-based decision-making at the patient level.